TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32941499

Group type: EXPERIMENTAL
Intervention: Maternal Antenatal Attachment Scale (MAAS)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Insecure avoidant adult attachment style
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Prenatal parental reflective functioning
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Insecure anxious adult attachment style
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Negative disinterested MAAS style
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Positively preoccupied MAAS style
Number of subjects: 78
Study: 34836766

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 96
Study: 33422019

Group type: EXPERIMENTAL
Intervention: Multiple imputation procedures under MAR and MNAR assumptions
Number of subjects: 0
Study: 35588754

Group type: EXPERIMENTAL
Intervention: Mixed vaccine regimen (Rotavac-Rotasiil-Rotavac, Rotasiil-Rotavac-Rotasiil, Rotavac-Rotasiil-Rotasiil, Rotasiil-Rotavac-Rotavac)
Number of subjects: 1979

Group type: COMPARATOR
Intervention: Single vaccine regimen (Rotavac-Rotavac-Rotavac, Rotasiil-Rotasiil-Rotasiil)
Number of subjects: 1979

Group type: COMPARATOR
Intervention: Single vaccine regimen
Number of subjects: 1979

Group type: EXPERIMENTAL
Intervention: Mixed vaccine regimen
Number of subjects: 1979
Study: 33713202

Group type: EXPERIMENTAL
Intervention: SAMGvent
Number of subjects: 17

Group type: COMPARATOR
Intervention: CON
Number of subjects: 17
Study: 35788416

Group type: EXPERIMENTAL
Intervention: SC CAS+IMD 1200 mg
Number of subjects: 969

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 969
Study: 32627500

Group type: EXPERIMENTAL
Intervention: Naomaitai Capsules
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Xiaoshuan Changrong Capsules
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Angong Niuhuang Pills
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao Granules
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Compound Danshen Dripping Pills
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Naoxintong Capsules
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Tongxinluo Capsules
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Naoxueshu Oral Liquid
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Zhuyu Tongmai Capsules
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Yinxingye Tablets
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Compound Danshen Tablets
Number of subjects: 52
Study: 33779002

Group type: EXPERIMENTAL
Intervention: S(+)-ibuprofen (S-IBU)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: R(−)-ibuprofen (R-IBU)
Number of subjects: 16
Study: 32606092

Group type: EXPERIMENTAL
Intervention: Public sector
Number of subjects: 2232

Group type: EXPERIMENTAL
Intervention: Outreach sector
Number of subjects: 2232
Study: 33917584

Group type: EXPERIMENTAL
Intervention: Spot reduction (SR) training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional resistance training (RT)
Number of subjects: 14
Study: 32210567

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Psychoeducation Programme (MBPP)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 46
Study: 34016111

Group type: EXPERIMENTAL
Intervention: Anastrozole + Mirena + Conservative Surgery (CS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Anastrozole + Mirena + transvaginal ultrasound-guided puncture-aspiration (TUGPA)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mirena + Conservative Surgery (CS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mirena + TUGPA
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mirena + Anastrozole
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Mirena (without Anastrozole)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (TUGPA)
Number of subjects: 31
Study: 34017999

Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 33
Study: 32658077

Group type: COMPARATOR
Intervention: Neoadjuvant Stereotactic Body Radiation Therapy (SBRT) - 33 Gy in 5 fractions to gross tumor plus abutting vessel, with or without 25 Gy in 5 fractions to pancreatic head/body and celiac/superior mesenteric artery.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fractionated Chemoradiation - 50.4 Gy in 28 fractions to gross tumor, superior mesenteric/celiac arteries, and enlarged lymph nodes with concurrent bolus 5‐FU, leucovorin, oxaliplatin, irinotecan or gemcitabine/nab‐paclitaxel.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Neoadjuvant Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fractionated Chemoradiation
Number of subjects: 43
Study: 34390300

Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 33332574

Group type: EXPERIMENTAL
Intervention: Fumaric acid esters (FAE)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 35133468

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg twice daily for 3 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 34658960

Group type: EXPERIMENTAL
Intervention: Smartphone-based, multi-domain cognitive training with gamified elements together with treatment as usual (TAU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham version of the same cognitive training together with TAU
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smartphone-based, multi-domain cognitive training with gamified elements
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham version of the same cognitive training
Number of subjects: 60
Study: 32751515

Group type: EXPERIMENTAL
Intervention: Exergame intervention for 24 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study: 35362188

Group type: EXPERIMENTAL
Intervention: Corticosteroid plus glycyrrhizin (48-week stepwise dose reduction of methylprednisolone plus glycyrrhizin)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Glycyrrhizin alone (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Corticosteroid plus glycyrrhizin
Number of subjects: 80
Study: 33676969

Group type: EXPERIMENTAL
Intervention: CT-P13 SC every 2 weeks (q2w) from W6 to W54
Number of subjects: 131

Group type: COMPARATOR
Intervention: CT-P13 IV every 8 weeks from W6 to W22
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: CT-P13 SC after switching from CT-P13 IV at W30/W54
Number of subjects: 131

Group type: COMPARATOR
Intervention: CT-P13 IV after switching to CT-P13 SC at W30/W54
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: CT-P13 SC and CT-P13 IV
Number of subjects: 131
Study: 32788280

Group type: EXPERIMENTAL
Intervention: 1‐percentage point increase in HbA1c
Number of subjects: 0
Study: 35786525

Group type: EXPERIMENTAL
Intervention: BLSFE (Bone Window Repositioning)
Number of subjects: 26

Group type: COMPARATOR
Intervention: LSFE (Lateral Sinus Floor Elevation without Bone Window Repositioning)
Number of subjects: 26
Study: 34408034

Group type: EXPERIMENTAL
Intervention: Positive deviance intervention (clinic-based and telephone-based counselling, 1-day participatory workshop)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 960
Study: 32438483

Group type: EXPERIMENTAL
Intervention: Telemonitoring (daily body weight measurement, daily recording of HF symptoms, and personalised education)
Number of subjects: 937

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Telemonitoring in NYHA class III or IV HF
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Telemonitoring in socially isolated patients
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: Telemonitoring in patients ≥70% adherent to body weight measurement
Number of subjects: 937
Study: 36335552

Group type: EXPERIMENTAL
Intervention: Medicinal cannabis (MC) as a prescription-only medication
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Posttrial access to MC
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Alternative pathways to access MC or reduce prescribed dosage
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Qualitative insights from interviews
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Calls for subsidisation
Number of subjects: 48
Study: 33502078

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg/day
Number of subjects: 14
Study: 33559134

Group type: EXPERIMENTAL
Intervention: Pine bark extract (PE) supplementation (25 mg or 50 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 20
Study: 33893778

Group type: EXPERIMENTAL
Intervention: Video Head Impulse Test (vHIT) assessment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (age and gender-matched unaffected individuals)
Number of subjects: 28
Study: 35302210

Group type: EXPERIMENTAL
Intervention: Ketamine 1.0 mg/kg (K1 group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ketamine 2.0 mg/kg (K2 group)
Number of subjects: 51
Study: 32628250

Group type: COMPARATOR
Intervention: Scheduled posthospitalization follow-up visit (n = 151)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: As-needed posthospitalization follow-up visit (n = 153)
Number of subjects: 304
Study: 36193903

Group type: EXPERIMENTAL
Intervention: 12-week tele-exercise training program (3 sessions/week, 30 min/session, weekly remote monitoring)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Usual care only (Control Group)
Number of subjects: 83
Study: 33812203

Group type: EXPERIMENTAL
Intervention: Transcranial Electrical Stimulation (TES) targeting anterior limbic areas (0.5 mA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 13
Study: 33036155

Group type: EXPERIMENTAL
Intervention: Stevia group (n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 28
Study: 35294608

Group type: EXPERIMENTAL
Intervention: Low-fat dairy diet (3.3 servings per day of low-fat milk, yogurt, and cheese)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Full-fat dairy diet (3.3 servings per day of full-fat milk, yogurt, and cheese)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Limited dairy diet (3 servings of nonfat milk per week)
Number of subjects: 72
Study: 616787628

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF
Number of subjects: 95
Study: 35835067

Group type: EXPERIMENTAL
Intervention: Augmented vision (AV, using interactive color overlays)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Black-and-white textbook-like illustrations (control)
Number of subjects: 48
Study: 34032504

Group type: EXPERIMENTAL
Intervention: Intermittent Androgen Deprivation Therapy (IADT)
Number of subjects: 8544
Study: 33947770

Group type: EXPERIMENTAL
Intervention: Cervical carotid stenting
Number of subjects: 115

Group type: COMPARATOR
Intervention: No cervical carotid stenting
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Tandem occlusions
Number of subjects: 115
Study: 34398347

Group type: EXPERIMENTAL
Intervention: Airtraq™
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: KingVision™
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Pentax AWS200™
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: VividTrac VT‐A100™
Number of subjects: 79

Group type: COMPARATOR
Intervention: Direct Macintosh laryngoscopy
Number of subjects: 79
Study: 36067985

Group type: EXPERIMENTAL
Intervention: Intervention group (education on nutrition, oral hygiene, and child stimulation)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 357

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 357
Study: 33245949

Group type: EXPERIMENTAL
Intervention: 16 Gy boost after breast conserving surgery and whole breast radiation (50 Gy)
Number of subjects: 2421

Group type: EXPERIMENTAL
Intervention: 26 Gy boost after breast conserving surgery and whole breast radiation (50 Gy)
Number of subjects: 2421

Group type: EXPERIMENTAL
Intervention: Cases (patients who developed a LR)
Number of subjects: 2421

Group type: COMPARATOR
Intervention: Controls (patients free of recurrence)
Number of subjects: 2421

Group type: EXPERIMENTAL
Intervention: Recurring tumors
Number of subjects: 2421
Study: 35775631

Group type: EXPERIMENTAL
Intervention: Curcumin treatment (200 mg twice daily for 6 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Curcumin treatment
Number of subjects: 37
Study: 32017242

Group type: EXPERIMENTAL
Intervention: Tibiofemoral joint shape
Number of subjects: 119
Study: 35186237

Group type: EXPERIMENTAL
Intervention: Nalbuphine + SAPB
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 34620153

Group type: EXPERIMENTAL
Intervention: Silybum marianum ointment
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 87
Study: 34315096

Group type: EXPERIMENTAL
Intervention: Home-visiting intervention
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Maternal depressed mood patterns
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Never depressed mothers
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Recurrent depressed mood
Number of subjects: 1238
Study: 32603380

Group type: EXPERIMENTAL
Intervention: bCPAP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 48
Study: 35446936

Group type: EXPERIMENTAL
Intervention: Eltrombopag (ELTR) combined with immunosuppressive therapy (IST)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) alone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Eltrombopag (ELTR) combined with immunosuppressive therapy (IST) in SAA
Number of subjects: 98

Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) alone in SAA
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Eltrombopag (ELTR) combined with immunosuppressive therapy (IST) in vSAA
Number of subjects: 98

Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) alone in vSAA
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Initial ELTR(−) patients who crossed over to ELTR
Number of subjects: 98

Group type: COMPARATOR
Intervention: Initial ELTR(+) patients
Number of subjects: 98
Study: 33462752

Group type: EXPERIMENTAL
Intervention: Entrectinib (600 mg research formulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Entrectinib (100-400 mg/m2, and 600-800 mg) once daily with food
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Entrectinib (600 mg single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Entrectinib (600 mg single doses, fasted state)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Entrectinib (marketed formulation in fed and fasted states)
Number of subjects: 0
Study: 32460816

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NCT) for 24 weeks
Number of subjects: 187

Group type: COMPARATOR
Intervention: Neoadjuvant endocrine therapy (NET) with goserelin and tamoxifen for 24 weeks
Number of subjects: 187
Study: 33271040

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 122
Study: 34562764

Group type: EXPERIMENTAL
Intervention: Grinding with fine diamond bur (46 μm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grinding with fine diamond bur followed by polishing with 2 tips (finisher and polisher)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grinding with extrafine diamond bur (30 μm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grinding with extrafine diamond bur followed by polishing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control - No adjustment
Number of subjects: 10
Study: 32450154

Group type: EXPERIMENTAL
Intervention: Supportive care plus immunosuppression
Number of subjects: 149

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 149
Study: 35201916

Group type: EXPERIMENTAL
Intervention: CYCL
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: OCCL
Number of subjects: 13

Group type: COMPARATOR
Intervention: CON
Number of subjects: 13
Study: 34763071

Group type: EXPERIMENTAL
Intervention: Basal insulin degludec (IDeg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Continuous subcutaneous insulin infusion (CSII) with aspart
Number of subjects: 52
Study: 33612519

Group type: EXPERIMENTAL
Intervention: Occupational stress
Number of subjects: 200
Study: 32256955

Group type: EXPERIMENTAL
Intervention: Alpha Lipoic Acid (ALA) 1200 mg (two 600 mg capsules/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (two maltodextrin capsules/day)
Number of subjects: 70
Study: 35880282

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) of quintuple needling combined with adductor relaxation method
Number of subjects: 80

Group type: COMPARATOR
Intervention: Adductor relaxation method
Number of subjects: 80
Study: 32356465

Group type: EXPERIMENTAL
Intervention: Apalutamide plus salvage radiotherapy (SRT)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Androgen‐deprivation therapy with a luteinizing hormone‐releasing hormone agonist or antagonist plus SRT
Number of subjects: 202
Study: 33080411

Group type: EXPERIMENTAL
Intervention: Dietary nitrate (12.6 mmol of concentrated beetroot juice)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitrate depleted placebo
Number of subjects: 12
Study: 33032532

Group type: EXPERIMENTAL
Intervention: 8-week physical activity and education program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study: 33545767

Group type: EXPERIMENTAL
Intervention: Continuous nursing based on Omaha System
Number of subjects: 102

Group type: COMPARATOR
Intervention: Routine nursing after discharge
Number of subjects: 102
Study: 32414323

Group type: EXPERIMENTAL
Intervention: Improved cookstove adoption
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Households headed by females
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Private house ownership
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Separate cooking location
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Fuel purchasing
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Health benefit perception
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Optimistic social interaction
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Traditional suitability perception
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Stove use demonstration experience
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Cheap price perception
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Availability of cookstove
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Fuel-saving benefit perception
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: More durable stove perception
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Lower educational level of head
Number of subjects: 5830

Group type: EXPERIMENTAL
Intervention: Fuel processing requirement
Number of subjects: 5830
Study: 35795968

Group type: EXPERIMENTAL
Intervention: Low-dose benzbromarone (LDBen) 25 mg daily
Number of subjects: 196

Group type: COMPARATOR
Intervention: Low-dose febuxostat (LDFeb) 20 mg daily
Number of subjects: 196
Study: 33449799

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg once every 2 weeks)
Number of subjects: 854

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 once every 3 weeks)
Number of subjects: 854
Study: 32209396

Group type: EXPERIMENTAL
Intervention: 1% yeast hydrolysate
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 1% and 3% yeast hydrolysate
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (0% yeast hydrolysate)
Number of subjects: 240
Study: 34782125

Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Number of subjects: 3081

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3081

Group type: EXPERIMENTAL
Intervention: Population-wide dissemination of DPP lifestyle modification
Number of subjects: 3081

Group type: EXPERIMENTAL
Intervention: Population-wide metformin therapy
Number of subjects: 3081
Study: 33429362

Group type: EXPERIMENTAL
Intervention: Variable practice condition (different distances to different goals) in physical execution
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Variable practice condition (different distances to different goals) in action observation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Constant practice condition (fixed distance and goal) in physical execution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Constant practice condition (fixed distance and goal) in action observation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Imagery condition
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: No-feedback groups in physical and observational conditions
Number of subjects: 90
Study: 32858740

Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH)
Number of subjects: 27513

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UH)
Number of subjects: 27513
Study: 33793979

Group type: EXPERIMENTAL
Intervention: Medicaid insurance
Number of subjects: 9475

Group type: EXPERIMENTAL
Intervention: Self-pay
Number of subjects: 9475

Group type: EXPERIMENTAL
Intervention: First-quartile NDI (highest deprivation)
Number of subjects: 9475

Group type: COMPARATOR
Intervention: Private insurance
Number of subjects: 9475
Study: 32869451

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 34245288

Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Intensive behavioral counseling
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Insular lesion presence
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Living with a partner
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Less dependency
Number of subjects: 196